Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Dr Caesar Atuire who has been appointed President of the International Association of Bioethics.

Caesar Atuire

The International Association of Bioethics (IAB) was founded in 1992 to facilitate contact, networking and exchange of ideas and resources amongst those working in bioethics and related fields in different parts of the world. The IAB encourages the development of bioethics research, teaching, and practice, while upholding the value of free, open, and reasoned discussion. It aims to promote the visibility and the dissemination of bioethics scholarly work and activism. It encourages the discussion of cross-cultural aspects of bioethics and seeks to support early career bioethicists and those working in regions that face challenges and barriers.

Dr Caesar Atuire is a philosopher and health ethicist from Ghana who is currently the Ethics Lead for NDM's MSc in International Health and Tropical Medicine.  He is also an Associate Professor of Applied Philosophy at the Department of Philosophy and Classics at the University of Ghana and an affiliate Instructor at the University of Washington’s Department of Bioethics and Humanities.  As the incoming President of the IAB, Caesar addressed The World Congress of Bioethics in Doha on 3 June.

Similar stories

Côte d’Ivoire becomes first nation to deploy R21 malaria vaccine

Côte d’Ivoire will become the first country to roll-out the new R21/Matrix-M™ vaccine with the first child vaccinated in Abidjan, marking a critical step and historic milestone in the global fight against malaria. 15 African countries are expected to introduce malaria vaccines with Gavi support in 2024, and countries plan to reach around 6.6 million children with the malaria vaccine in 2024 and 2025. The new vaccine has been authorised by Ghana, Nigeria, Burkina Faso and the Central African Republic, and many others are preparing to receive shipments.